Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells.
1992 · PubMed · 103 citations
I
Ilana Stancovski
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
14
Papers
2.0K
Citations
14
h-index
14
i10-index
Ilana Stancovski is an academic researcher from Technion – Israel Institute of Technology. The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & HER2/EGFR in Cancer Research & Ubiquitin and proteasome pathways. The author has an h-index of 14, co-authored 12 publications.
Papers by this author
worksMolecular and clinical aspects of the Neu/ErbB-2 receptor tyrosine kinase
1994 · Cancer treatment and research · 28 citations
https://doi.org/10.1007/978-1-4615-2592-9_9
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
1992 · The Journal of Steroid Biochemistry and Molecular Biology · 24 citations
https://doi.org/10.1016/0960-0760(92)90192-l
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat